Search judgments by proposition, citation, court, judge or legal topic, then move directly into the source-grounded case analysis.
Results update automatically as you type.
England and Wales decisions
Decisions matching the current search
Generics (UK) Ltd & Ors v AstraZenica AB [2025] EWCA Civ 903 (16 July 2025)
The Court of Appeal dismissed AstraZeneca’s appeal and upheld invalidity findings on dapagliflozin’s patent and SPCs for lack of plausibility and arbitrary selection.
Court of Appeal upheld findings that AstraZeneca’s dapagliflozin patent was invalid for lack of inventive step and insufficiency, and was an arbitrary selection from prior art.
The High Court held AstraZeneca’s dapagliflozin patent and related SPCs invalid for insufficiency and lack of inventive step.
Generics (UK) Ltd Ltd v Astrazeneca AB [2025] EWHC 1012 (Pat) (28 April 2025)
The Patents Court held that AstraZeneca’s dapagliflozin patent and related SPCs were invalid because the claimed therapeutic effect was not made plausible.
Explore more
